SX 011

• CAT Number: I010798
• CAS Number: 309913-42-6
• Molecular Formula: C26H27ClFN3O3
• Molecular Weight: 483.96
• Purity: ≥95%
• Synonyms: 2-[6-chloro-5-[4-[(4-fluorophenyl)methyl]piperidine-1-carbonyl]-1-methylindol-3-yl]-N,N-dimethyl-2-oxoacetamide
• InChI: InChI=1S/C26H27ClFN3O3/c1-29(2)26(34)24(32)21-15-30(3)23-14-22(27)20(13-19(21)23)25(33)31-10-8-17(9-11-31)12-16-4-6-18(28)7-5-16/h4-7,13-15,17H,8-12H2,1-3H3
• InChIKey: GUTYHDCSDBBMGW-UHFFFAOYSA-N
• SMILES: CN1C=C(C2=CC(=C(C=C21)Cl)C(=O)N3CCC(CC3)CC4=CC=C(C=C4)F)C(=O)C(=O)N(C)C

SX 011（Cat No.:I010798）is a novel small molecule compound currently under investigation for its therapeutic potential in cancer and metabolic diseases. It acts by targeting specific enzymes involved in tumor cell proliferation and metabolic dysregulation. Research indicates that SX 011 may help inhibit the growth of various cancer types, including breast and lung cancer, by interfering with key cellular pathways. Additionally, the compound shows promise in improving insulin sensitivity and managing metabolic disorders such as diabetes. Ongoing preclinical studies aim to evaluate its safety, efficacy, and potential for broader clinical applications.